PT Phapros Tbk (IDX: PEHA)
Health Care · Pharmaceuticals · ID
Rp288.00
+2.86% today · -11.7% 1Y
PT Phapros Tbk (IDX: PEHA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.52M and employs 1,255 people.
Over the last twelve months the share price has lost 11.7%, trading between 206.00 and 460.00.
Tweenvest scores PT Phapros Tbk across four factors: quality 67/100, value 75/100, dividend 51/100. Its strongest factor is value.
PEHA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.52M
- Revenue (TTM)
- $53.97M
- P/E
- 5.91
- EPS
- 48.74
- Dividend yield
- 1.74%
- Beta (5Y)
- 0.40
- 52-week high
- Rp460.00
- 52-week low
- Rp206.00
- Avg volume (3M)
- —
- Shares outstanding
- 840.00M
- Employees
- 1,255
- Next earnings
- —
About PT Phapros Tbk
PT Phapros, Tbk is a prominent Indonesian company operating within the pharmaceutical and healthcare sectors. Its operations are broadly categorized into four key divisions: Over-the-Counter (OTC) products, Ethical drugs, Generic drug manufacturing, and Toll Manufacturing services. The company's OTC offerings feature well-known brands such as Antimo Anak, Livron B Plek, Noza, Hemorogard, and Bioron. In addition to supplying generic medications to government institutions and hospitals, PT Phapros also serves as a contract manufacturer for other pharmaceutical companies and provides various medical devices. Established in 1954 with its headquarters located in Jakarta, Indonesia, the company further extends its market reach by exporting products internationally. PT Phapros, Tbk functions as a subsidiary under the umbrella of PT Kimia Farma (Persero) Tbk.
- ISIN
- ID1000147507
- Founded
- 1954
- Listed since
- Dec 26, 2018
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tvardi Therapeutics, Inc.NasdaqCM: TVRD | $13.74M | $1.03 | 0.00% |
| WooGene B&G Co., LtdKOSDAQ: A018620 | $13.72M | ₩2,660.00 | -0.19% |
| Citius Pharmaceuticals, Inc.NasdaqCM: CTXR | $13.71M | $0.48 | -3.62% |
| Lactose (India) LimitedBSE: 524202 | $13.52M | Rs103.95 | -1.38% |
| Klaria Pharma Holding AB (publ.)OM: KLAR | $13.36M | Skr0.53 | -2.58% |
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.90M | Tk15.30 | -8.38% |
Figures last refreshed Oct 11, 2026.